Literature DB >> 8702971

Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X.

Q Huang1, P F Neuenschwander, A R Rezaie, J H Morrissey.   

Abstract

Tissue factor (TF) is the protein cofactor for factor VIIa (FVIIa), the first serine protease of the clotting cascade. Previous studies using alanine mutagenesis have identified TF residues Lys165 and Lys166 as important for factor X (FX) activation, hypothesizing either that these residues interact with phospholipid head groups or that they directly or indirectly promote macromolecular substrate binding. In the recently reported x-ray crystal structure of the isolated extracellular domain of TF, both Lys165 and Lys166 are solvent-exposed and predicted to be near the phospholipid surface in intact TF. We hypothesized that these residues may in fact be ideally positioned to interact with the 4-carboxyglutamate-rich domain (Gla domain) of FX. We therefore predicted that mutations at Lys165 and Lys166 should have no effect on the activation of Gla domainless FX. To test this hypothesis, we mutated both residues Lys165 and Lys166 of TF to Ala, Glu, or Gln and examined the ability of these double mutants to support FVIIa-mediated activation of FX, Gla domainless FX, and factor IX (FIX). Each TF mutant was equivalent to wild-type TF in both FVIIa binding and promotion of FVIIa amidolytic activity. However, all three mutants were markedly deficient in supporting FIX and FX activation, with FX activation rates decreased more than FIX activation rates. In both reactions, the TF mutants exhibited different extents of activity: Gln165-Gln166 > Ala165-Ala166 > Glu165-Glu166. In sharp contrast, all three TF mutants were equivalent to wild-type TF in supporting activation of Gla domainless FX by FVIIa. Interestingly, the deficiency of the mutants in FX activation was less pronounced when Gla domainless FVIIa was used in place of native FVIIa. Together, these findings suggest that TF residues Lys165 and Lys166 contribute to a binding site for the Gla domain of FX (and perhaps other substrates) and that this interaction may be facilitated by the presence of the Gla domain of FVIIa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702971     DOI: 10.1074/jbc.271.36.21752

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

2.  Lipid specificity of the membrane binding domain of coagulation factor X.

Authors:  M P Muller; Y Wang; J H Morrissey; E Tajkhorshid
Journal:  J Thromb Haemost       Date:  2017-09-01       Impact factor: 5.824

3.  Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor.

Authors:  Y Z Ohkubo; J H Morrissey; E Tajkhorshid
Journal:  J Thromb Haemost       Date:  2010-02-24       Impact factor: 5.824

4.  A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties.

Authors:  Xin Huang; Wei-Qun Ding; Joshua L Vaught; Roman F Wolf; James H Morrissey; Roger G Harrison; Stuart E Lind
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

5.  Structure and dynamics of zymogen human blood coagulation factor X.

Authors:  Divi Venkateswarlu; Lalith Perera; Tom Darden; Lee G Pedersen
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

Review 6.  Recent estimates of the structure of the factor VIIa (FVIIa)/tissue factor (TF) and factor Xa (FXa) ternary complex.

Authors:  Chang Jun Lee; Vasu Chandrasekaran; Sangwook Wu; Robert E Duke; Lee G Pedersen
Journal:  Thromb Res       Date:  2010-02-13       Impact factor: 3.944

7.  Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated Protein C: role of magnesium at physiological calcium.

Authors:  Kanagasabai Vadivel; Sayeh Agah; Amanda S Messer; Duilio Cascio; Madhu S Bajaj; Sriram Krishnaswamy; Charles T Esmon; Kaillathe Padmanabhan; S Paul Bajaj
Journal:  J Mol Biol       Date:  2013-02-20       Impact factor: 5.469

8.  Molecular dynamic simulations of the binary complex of human tissue factor (TF(1-242) ) and factor VIIa (TF(1-242) /FVIIa) on a 4:1 POPC/POPS lipid bilayer.

Authors:  C J Lee; S Wu; L J Bartolotti; L G Pedersen
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

Review 9.  Regulation of tissue factor coagulant activity on cell surfaces.

Authors:  L V M Rao; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

Review 10.  Structure-Function Relationship of the Interaction between Tissue Factor and Factor VIIa.

Authors:  Joshua M Gajsiewicz; James H Morrissey
Journal:  Semin Thromb Hemost       Date:  2015-09-26       Impact factor: 4.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.